As VEGF is highly abundant in the pancreatic tumor milieu, we decided to further segregate clones based on their ability to bind to VEGF-treated HUVECs vs. tumor conditioned media (TCM)-treated HUVECs. The gene discussed is VEGFA; the disease is neoplasm.